Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Seshagiri, Somasekar

Class:IdPerson:2399668
_displayNameSeshagiri, Somasekar
_timestamp2012-07-12 16:15:45
created[InstanceEdit:2399709] Orlic-Milacic, M, 2012-07-12
firstnameSomasekar
initialS
surnameSeshagiri
(author)[LiteratureReference:2399688] Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation
[LiteratureReference:5690747] Loss of the tumor suppressor BAP1 causes myeloid transformation
[LiteratureReference:6790370] RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
[LiteratureReference:9666001] Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations
[Change default viewing format]
No pathways have been reviewed or authored by Seshagiri, Somasekar (2399668)